Sensei Biotherapeutics Inc (SNSE) Stock Price, Quote & News

Company Profile

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune ch...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 243 8000

Website: www.senseibio.com

Address:

1405 Research Boulevard, Suite 125, Rockville, United States

Stackdoe101 Feb. 24 at 4:43 AM

$SNSE 🙃✨️

0 · Reply

TinyTiger19 Feb. 24 at 12:02 AM

*@SqueezeSharkie on a different level better than 90% of the traders on this platform. If you’re not tuned in, that’s a miss, make sure to follow him doesn’t cost you anything but a simple click.💎 $ATCX $SNSE $FBYD $MSGM * on my wl

0 · Reply

ElBambino23 Feb. 23 at 11:54 PM

$SNSE multiple attempts at $35 but didn’t crack it on the higher volume of the day. Now it’s a double maybe triple top and closed below the opening. looking like it’s time for a price correction a flush!

0 · Reply

MrCrocodileteeth_ Feb. 23 at 11:50 PM

@SqueezeSharkie a real legend for calling that run! I suggest following him below, Great trader! 🔥 Also nice move on $SNSE $RXT $SGN $NCI

0 · Reply

NoEmotionzTrade Feb. 23 at 10:55 PM

$GIPR 2m free float market cap, almost no shares to short Break .85 and this can squeeze like $SNSE $RXT $SGN

0 · Reply

oKarl Feb. 23 at 10:07 PM

$SNSE good price action

0 · Reply

smartmoney43 Feb. 23 at 9:42 PM

$SNSE cant wait for $100 🤑🤑

0 · Reply

MB6288 Feb. 23 at 9:22 PM

$SNSE All you fuckers buying this at this level I hope you get fucking smoked!

0 · Reply

smartmoney43 Feb. 23 at 6:09 PM

$SNSE 😍😍

0 · Reply

MochiMeerkat Feb. 23 at 5:14 PM

)@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. Not following yet? That’s on you. Free game, unreal value. 🐐 $BNAI $WHLR $MLEC $SNSE <<>>

0 · Reply

Sensei Biotherapeutics Announces Acquisition of Faeth Therapeutics and $200 Million Concurrent Private Placement

Jan 7, 2026, 8:00 AM EST - 6 weeks ago

Egle Therapeutics Appoints John Celebi as Chief Executive Officer

Nov 14, 2025, 7:30 AM EST - 3 months ago

Sensei Biotherapeutics Reports Third Quarter 2025 Financial Results

Oct 30, 2025, 9:00 AM EDT - 4 months ago

Sensei Biotherapeutics Announces Initiation of Strategic Review to Maximize Shareholder Value

Oct 17, 2025, 8:00 AM EDT - 4 months ago

Sensei Biotherapeutics Reports New Clinical Results Highlighting Durable Progression Free Survival Data for Solnerstotug in PD-(L)1 Resistant Tumors at the ESMO Congress 2025

Sep 23, 2025, 7:30 AM EDT - 5 months ago

Sensei Biotherapeutics to Host Virtual KOL Event to Discuss Full Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors on October 20, 2025

Sep 3, 2025, 8:00 AM EDT - 6 months ago

Sensei Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 5, 2025, 7:30 AM EDT - 7 months ago

Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Jul 30, 2025, 7:30 AM EDT - 7 months ago

Sensei Biotherapeutics to Present Clinical Data from the Phase 1 Dose Expansion Cohort of Solnerstotug at the ESMO Congress 2025

Jun 13, 2025, 7:30 AM EDT - 9 months ago

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

May 6, 2025, 7:30 AM EDT - 10 months ago

Sensei Biotherapeutics Reports First Quarter 2025 Financial Results and Updates on Clinical Progress

Apr 2, 2025, 7:30 AM EDT - 11 months ago

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Mar 28, 2025, 7:30 AM EDT - 11 months ago

Sensei Biotherapeutics Reports Full Year 2024 Financial Results and Update on Clinical Progress

Mar 27, 2025, 4:05 PM EDT - 11 months ago

Sensei Biotherapeutics Reports Favorable Preliminary Dose Expansion Data for Solnerstotug in PD-(L)1 Resistant Tumors

Feb 4, 2025, 7:30 AM EST - 1 year ago

Sensei Biotherapeutics to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Jan 8, 2025, 7:30 AM EST - 1 year ago

Sensei Biotherapeutics Provides Corporate Update and Highlights Key Upcoming Milestones

Nov 27, 2024, 4:05 PM EST - 1 year ago

Sensei Biotherapeutics to Participate in Citi's 2024 Global Healthcare Conference

Nov 14, 2024, 7:30 AM EST - 1 year ago

Sensei Biotherapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Oct 29, 2024, 7:30 AM EDT - 1 year ago

Sensei Biotherapeutics to Present at Two Upcoming Scientific Conferences

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Sensei Biotherapeutics to Present Preclinical Data on SNS-103 at the CRI-ENCI Eighth International Immunotherapy Conference

Sep 4, 2024, 7:30 AM EDT - 1 year ago

Sensei Biotherapeutics to Present at Upcoming Conferences

Aug 6, 2024, 7:30 AM EDT - 1 year ago

Sensei Biotherapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

May 30, 2024, 7:30 AM EDT - 1 year ago

Sensei Biotherapeutics to Participate in Jefferies Global Healthcare Conference

May 23, 2024, 5:10 PM EDT - 1 year ago

Sensei Biotherapeutics Presents Promising Clinical Data from Phase 1 Dose Escalation Study of SNS-101

May 10, 2024, 11:45 AM EDT - 1 year ago

EGLE Therapeutics Strengthens its Leadership Team with the Appointment of Pejvack Motlagh, MD, MSc, as Chief Medical Officer and its Board of Directors with Appointment of John Celebi, MBA, as Independent Board Member

May 9, 2024, 7:30 AM EDT - 1 year ago

Sensei Biotherapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

Apr 24, 2024, 4:05 PM EDT - 1 year ago

Sensei Biotherapeutics to Present Topline Clinical Data from the SNS-101 Phase I Dose Escalation Study at the 2024 ASCO Annual Meeting

Apr 9, 2024, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Participate in Canaccord Genuity's Horizons in Oncology Virtual Conference

Apr 4, 2024, 4:05 PM EDT - 2 years ago

Sensei Biotherapeutics Announces Nature Communications Publication Describing Mechanism of Action of SNS-101 Selectively Targeting the Active Form of VISTA within the Tumor Microenvironment

Mar 22, 2024, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Participate in the 3rd Annual VISTA Symposium

Mar 6, 2024, 7:30 AM EST - 2 years ago

Sensei Biotherapeutics to Present New Preclinical Data at Upcoming Scientific Conferences

Feb 28, 2024, 7:30 AM EST - 2 years ago

Sensei Biotherapeutics Reports Full Year 2023 Financial Results and Recent Business Highlights

Nov 7, 2023, 7:30 AM EST - 2 years ago

Sensei Biotherapeutics Reports Third Quarter 2023 Financial Results and Recent Business Highlights

Nov 3, 2023, 4:05 PM EDT - 2 years ago

Sensei Biotherapeutics Reports Favorable Clinical Data for SNS-101 at 2023 SITC Annual Meeting

Nov 1, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Appoints Stephanie Krebs, MS, MBA, as Chief Business Officer

Oct 25, 2023, 9:05 AM EDT - 2 years ago

Sensei Biotherapeutics to Present Initial Clinical Data from Dose Escalation Trial of SNS-101 at 2023 SITC Annual Meeting

Oct 23, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Presents Trial-in-Progress Poster for Phase 1/2 Clinical Study of SNS-101 at ESMO 2023

Sep 27, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Announces Initiation of Combination Arm for Phase 1/2 Clinical Study of SNS-101 with Regeneron's Libtayo®

Sep 21, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Presents New Preclinical Data Reinforcing SNS-101 Pharmacokinetic Profile, Safety Characteristics and Mechanism of Action at the Seventh CRI-ENCI-AACR International Cancer Immunotherapy Conference

Sep 13, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Present New Preclinical Data Supporting Mechanism of Action, Pharmacokinetic Profile and Safety Characteristics for SNS-101, a Conditionally Active VISTA-blocking Antibody, at the Seventh CRI-ENCI-AACR International Cancer Immuno

Aug 30, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Participate in Upcoming Investor Conferences

Aug 3, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Aug 2, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Participate in Canaccord Genuity's 43rd Annual Growth Conference

Jun 13, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics to Host Virtual Key Opinion Leader Event, “A New Vista for Cancer Care: Exploring SNS-101's Potential as a Transformative Treatment Option for Patients with Solid Tumors”

Jun 1, 2023, 7:30 AM EDT - 2 years ago

Sensei Biotherapeutics Announces First Patient Dosed in Phase 1/2 Clinical Trial of SNS-101, a Conditionally Active VISTA-blocking Antibody, for the Treatment of Advanced Solid Tumors

May 9, 2023, 7:30 AM EDT - 3 years ago

Sensei Biotherapeutics Reports First Quarter 2023 Financial Results and Recent Business Highlights

Apr 20, 2023, 7:30 AM EDT - 3 years ago

Sensei Biotherapeutics Announces IND Clearance by U.S. FDA Enabling Phase 1 Initiation for SNS-101, a Conditionally Active VISTA-Blocking Antibody

Apr 18, 2023, 4:05 PM EDT - 3 years ago

Sensei Biotherapeutics Presents New Preclinical Data on SNS-103 Targeting ENTPDase1 (CD39) at the American Association for Cancer Research (AACR) Annual Meeting 2023

Mar 30, 2023, 7:30 AM EDT - 3 years ago

Sensei Biotherapeutics to Participate in Cantor Fitzgerald's Future of Oncology Virtual Symposium

Mar 28, 2023, 7:30 AM EDT - 3 years ago

Sensei Biotherapeutics Reports Full Year 2022 Financial Results and Recent Business Highlights

Stackdoe101 Feb. 24 at 4:43 AM

$SNSE 🙃✨️

0 · Reply

TinyTiger19 Feb. 24 at 12:02 AM

0 · Reply

ElBambino23 Feb. 23 at 11:54 PM

0 · Reply

MrCrocodileteeth_ Feb. 23 at 11:50 PM

@SqueezeSharkie a real legend for calling that run! I suggest following him below, Great trader! 🔥 Also nice move on $SNSE $RXT $SGN $NCI

0 · Reply

NoEmotionzTrade Feb. 23 at 10:55 PM

$GIPR 2m free float market cap, almost no shares to short Break .85 and this can squeeze like $SNSE $RXT $SGN

0 · Reply

oKarl Feb. 23 at 10:07 PM

$SNSE good price action

0 · Reply

smartmoney43 Feb. 23 at 9:42 PM

$SNSE cant wait for $100 🤑🤑

0 · Reply

MB6288 Feb. 23 at 9:22 PM

$SNSE All you fuckers buying this at this level I hope you get fucking smoked!

0 · Reply

smartmoney43 Feb. 23 at 6:09 PM

$SNSE 😍😍

0 · Reply

MochiMeerkat Feb. 23 at 5:14 PM

)@SqueezeSharkie operating on another level 🧠❄️ Cold vision, real substance. Not following yet? That’s on you. Free game, unreal value. 🐐 $BNAI $WHLR $MLEC $SNSE <<>>

0 · Reply

OfficialStocktwitsUser Feb. 23 at 4:31 PM

$SNSE RSI: 98.12, MACD: 4.7580 Vol: 8.88, MA20: 13.48, MA50: 11.32 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

1 · Reply

FreyBentos Feb. 23 at 4:31 PM

$SNSE looking ready to squeeze in here, price just keeps holding up and creeping higher.

0 · Reply

Indyson Feb. 23 at 4:03 PM

$SLS we gonna have one of those $SNSE moves soon?

0 · Reply

firsthole Feb. 23 at 2:59 PM

$IBG $SNSE $SMX $TIRX $BNAI GO AWAY!!! TIRX BOARD. GO PUMP SOMEWHERE ELSE

0 · Reply

LUNR_Gateway_SpaceExIPO Feb. 23 at 1:53 PM

$IBG $MLEC $RXT $SNSE $TIRX 🆘⚠️🆘⚠️🆘 Four Years of Paradise Profit and four followers tells me all we need to know! NO THANK YOU 🙂‍↔️

1 · Reply

TinyTiger19 Feb. 23 at 12:33 PM

$RXT $SNSE $MLEC $ATOM.X _

0 · Reply

TradingFlow_ Feb. 23 at 12:02 PM

NEVER chase those tickers that are up 500% and running. Easy way to get burned! If you want to be early on a $RXT $SNSE $BNAI $MLEC type of run , be sure to check out $IBG IBG has one of the smallest floats on the market , Only 500k shares outstanding! Merger news due in a few weeks - these are the stocks you get in before the crowd and sell when they go parabolic! I added a large position on IBG waiting for a massive run. Not saying its going to run to 100$ like SMX but they could run it 300% from here.

0 · Reply

Stock_Catcher Feb. 23 at 1:23 AM

Money Monday Watchlist Pt. 3 $SNSE $YIBO $RBOT $FJET $NBY Let's Pop Off Tomorrow Team

0 · Reply

frbdcsbjax Feb. 22 at 9:53 PM

$SNSE what is the expectation for Monday?

1 · Reply

PaulLaurent Feb. 22 at 7:41 PM

🚀📈 Top Gainers 📈🚀Last Week $RXT $SNSE $MLEC $ATOM.X $NCI

0 · Reply

smartmoney43 Feb. 22 at 7:35 PM

$SNSE 40+ this week 💰 🤑

0 · Reply

Market Cap	42.25M
Revenue (ttm)	0.00
Net Income (ttm)	-30.16M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	222,800
Avg Vol	335,762
Day's Range	N/A - N/A
Shares Out	1.26M
Stochastic %K	91%
Beta	0.28
Analysts	Hold
Price Target	$35.00